SEATTLE and VANCOUVER, British Columbia, Sept. 26, 2018 /PRNewswire/ -- Achieve Life
Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical
company committed to the global development and commercialization
of cytisine for smoking cessation, today announced that
Rick Stewart, Chairman and Chief
Executive Officer, will present at the Ladenburg Thalmann 2018
Healthcare Conference being held Tuesday,
October 2nd in New York
City at the Sofitel Hotel New York.
The Company's presentation will take place at 10:00am EDT. A live webcast of the presentation
can be accessed at
http://ir.achievelifesciences.com/events-and-webcasts. A replay of
the webcast will also be archived on Achieve's website following
the conference.
About Achieve & Cytisine
Achieve's focus is to
address the global smoking health epidemic through the development
and commercialization of cytisine. Tobacco use is currently the
leading cause of preventable death and is responsible for nearly
six million deaths annually worldwide1. It is estimated
that 28.6% of all cancer deaths in the U.S. are attributable to
cigarette smoking2.
Cytisine is a plant-based alkaloid with a high binding affinity
to the nicotinic acetylcholine receptor. Two prior, large-scale
Phase 3 clinical studies of cytisine, with favorable outcomes, have
been successfully completed in over 2,000 patients. The TASC trial
was a 740 patient, double-blind, placebo controlled trial conceived
by Professor Robert West at
University College London and funded by the U.K. National
Prevention Research Initiative. The CASCAID trial was a 1,310
patient, single-blind, non-inferiority trial comparing cytisine to
nicotine replacement therapy (NRT). The CASCAID trial was conceived
by Dr. Natalie Walker, National
Institute for Health Innovation, University of Auckland and funded by the Health Research
Council of New Zealand. Both
trials were published in the New England Journal of
Medicine.
Achieve Contact
Jason Wong
jwong@bplifescience.com
(415) 375-3340 ext. 4
1World Health Organization. WHO Report on
the Global Tobacco Epidemic, 2011, Geneva: World Health Organization,
2011.
2Annals of Epidemiology, Volume 25, Issue
3, 179 - 182.e1
View original content to download
multimedia:http://www.prnewswire.com/news-releases/achieve-to-present-at-the-ladenburg-thalmann-2018-healthcare-conference-on-october-2-2018-300718408.html
SOURCE Achieve Life Sciences, Inc.